187 related articles for article (PubMed ID: 33811512)
1. Feasibility, safety, and efficacy of ultrasound-guided transperineal laser ablation for the treatment of benign prostatic hyperplasia: a single institutional experience.
Frego N; Saita A; Casale P; Diana P; Contieri R; Avolio PP; Lazzeri M; Hurle R; Buffi NM; Guazzoni GF; Lughezzani G
World J Urol; 2021 Oct; 39(10):3867-3873. PubMed ID: 33811512
[TBL] [Abstract][Full Text] [Related]
2. Ultrasound-guided transperineal laser ablation for percutaneous treatment of benign prostatic hyperplasia: a new minimally invasive interventional therapy.
Cai HJ; Fang JH; Kong FL; Xu CK; Chen CH; Wang W; Huang B
Acta Radiol; 2022 Apr; 63(4):553-558. PubMed ID: 33779301
[TBL] [Abstract][Full Text] [Related]
3. Transperineal laser ablation for percutaneous treatment of benign prostatic hyperplasia: a feasibility study. Results at 6 and 12 months from a retrospective multi-centric study.
Pacella CM; Patelli G; Iapicca G; Manenti G; Perretta T; Ryan CP; Esposito R; Mauri G
Prostate Cancer Prostatic Dis; 2020 Jun; 23(2):356-363. PubMed ID: 31827239
[TBL] [Abstract][Full Text] [Related]
4. Transperineal Laser Ablation for Percutaneous Treatment of Benign Prostatic Hyperplasia: A Feasibility Study.
Patelli G; Ranieri A; Paganelli A; Mauri G; Pacella CM
Cardiovasc Intervent Radiol; 2017 Sep; 40(9):1440-1446. PubMed ID: 28474112
[TBL] [Abstract][Full Text] [Related]
5. Transperineal interstitial laser ablation of the prostate, a novel option for minimally invasive treatment of benign prostatic obstruction.
de Rienzo G; Lorusso A; Minafra P; Zingarelli M; Papapicco G; Lucarelli G; Battaglia M; Ditonno P
Eur Urol; 2021 Jul; 80(1):95-103. PubMed ID: 32868137
[TBL] [Abstract][Full Text] [Related]
6. Ultrasound-guided SoracteLite™ transperineal laser ablation (TPLA) of the prostate for the treatment of symptomatic benign prostatic hyperplasia (BPH): a prospective single-center experience.
Laganà A; Di Lascio G; Di Blasi A; Licari LC; Tufano A; Flammia RS; De Carolis A
World J Urol; 2023 Apr; 41(4):1157-1162. PubMed ID: 36853444
[TBL] [Abstract][Full Text] [Related]
7. Transperineal laser ablation as treatment for benign prostatic obstruction: Safety, feasibility and functional outcomes-A pilot study.
van Kollenburg R; van Riel L; Bloemen P; de Reijke T; Beerlage H; de Bruin D; Oddens J
BJUI Compass; 2024 Jan; 5(1):52-59. PubMed ID: 38179027
[TBL] [Abstract][Full Text] [Related]
8. Transperineal Laser Ablation Treatment for Lower Urinary Tract Symptoms Due to Benign Prostatic Obstruction: Protocol for a Prospective In Vivo Pilot Study.
van Kollenburg RAA; van Riel LAMJG; Bloemen PR; Oddens JR; de Reijke TM; Beerlage HP; de Bruin DM
JMIR Res Protoc; 2020 Jan; 9(1):e15687. PubMed ID: 31961326
[TBL] [Abstract][Full Text] [Related]
9. Ultrasound-guided perineal laser ablation versus prostatic arterial embolization for benign prostatic hyperplasia: two similar short-term efficacies.
Cai H; Zhu C; Fang J
Acta Radiol; 2023 May; 64(5):2033-2039. PubMed ID: 36437581
[TBL] [Abstract][Full Text] [Related]
10. Temporary implantable nitinol device (TIND): a novel, minimally invasive treatment for relief of lower urinary tract symptoms (LUTS) related to benign prostatic hyperplasia (BPH): feasibility, safety and functional results at 1 year of follow-up.
Porpiglia F; Fiori C; Bertolo R; Garrou D; Cattaneo G; Amparore D
BJU Int; 2015 Aug; 116(2):278-87. PubMed ID: 25382816
[TBL] [Abstract][Full Text] [Related]
11. 3-T MRI and clinical validation of ultrasound-guided transperineal laser ablation of benign prostatic hyperplasia.
Manenti G; Perretta T; Calcagni A; Ferrari D; Ryan CP; Fraioli F; Meucci R; Malizia A; Iacovelli V; Agrò EF; Floris R
Eur Radiol Exp; 2021 Sep; 5(1):41. PubMed ID: 34532768
[TBL] [Abstract][Full Text] [Related]
12. The Design and Rationale of a Multicentre Randomised Controlled Trial Comparing Transperineal Percutaneous Laser Ablation With Transurethral Resection of the Prostate for Treating Benign Prostatic Hyperplasia.
Zhang W; Zhang W; Guo Q; Chen L; Meng Z; Xu Y; Cao N; Hu B; Qian B
Front Surg; 2021; 8():755957. PubMed ID: 34733883
[No Abstract] [Full Text] [Related]
13. Aquablation - image-guided robot-assisted waterjet ablation of the prostate: initial clinical experience.
Gilling P; Reuther R; Kahokehr A; Fraundorfer M
BJU Int; 2016 Jun; 117(6):923-9. PubMed ID: 26477826
[TBL] [Abstract][Full Text] [Related]
14. Bipolar plasma enucleation of the prostate vs open prostatectomy in large benign prostatic hyperplasia cases - a medium term, prospective, randomized comparison.
Geavlete B; Stanescu F; Iacoboaie C; Geavlete P
BJU Int; 2013 May; 111(5):793-803. PubMed ID: 23469933
[TBL] [Abstract][Full Text] [Related]
15. Transperineal Laser Ablation of the Prostate for Symptomatic Benign Prostatic Hyperplasia: Long-Term Follow-Up in 40 Patients.
Patelli G; Altieri VM; Ierardi AM; Carnevale A; Chizzoli E; Baronchelli F; Trimarchi R; Carrafiello G
J Vasc Interv Radiol; 2024 May; ():. PubMed ID: 38705571
[TBL] [Abstract][Full Text] [Related]
16. Second-generation of temporary implantable nitinol device for the relief of lower urinary tract symptoms due to benign prostatic hyperplasia: results of a prospective, multicentre study at 1 year of follow-up.
Porpiglia F; Fiori C; Amparore D; Kadner G; Manit A; Valerio M; Nicolaas L; Ho BSH; Alonso S; Schulman C; Barber N
BJU Int; 2019 Jun; 123(6):1061-1069. PubMed ID: 30382600
[TBL] [Abstract][Full Text] [Related]
17. [5-year follow-up to transurethral vaporesection of the prostate using the 2 micron continuous wave laser for the treatment of benign prostatic hyperplasia].
Xu Y; Sun DC; Yang Y; Wei ZT; Hong BF; Zhang X
Zhonghua Wai Ke Za Zhi; 2013 Feb; 51(2):119-22. PubMed ID: 23711003
[TBL] [Abstract][Full Text] [Related]
18. Three years outcomes of transperineal laser ablation of the prostate.
Minafra P; DE Rienzo G; Gerbasi S; Cindolo L; Battaglia M; Ditonno P
Minerva Urol Nephrol; 2023 Aug; 75(4):471-478. PubMed ID: 37314812
[TBL] [Abstract][Full Text] [Related]
19. A prospective study of transperineal prostatic block for transurethral needle ablation for benign prostatic hyperplasia: the Emory University Experience.
Issa MM; Perez-Brayfield M; Petros JA; Anastasia K; Labadia AJ; Miller LE
J Urol; 1999 Nov; 162(5):1636-9. PubMed ID: 10524886
[TBL] [Abstract][Full Text] [Related]
20. Aquablation of the prostate for the treatment of lower urinary tract symptoms in men with benign prostatic hyperplasia.
Hwang EC; Jung JH; Borofsky M; Kim MH; Dahm P
Cochrane Database Syst Rev; 2019 Feb; 2(2):CD013143. PubMed ID: 30759311
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
